Evidence map›Paper›PMID 34356728›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Molecular Analysis of Streptomycin Resistance Genes in Clinical Strains of

Álvaro Rodríguez-García, Rosa E Mares-Alejandre, Patricia L A Muñoz-Muñoz, Samuel Ruvalcaba-Ruiz, Ricardo A González-Sánchez, Johanna Bernáldez-Sarabia, Samuel G Meléndez-López, Alexei F Licea-Navarro, Marco A Ramos-Ibarra

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Comparison of Phenotype and Genotype Virulence and Antimicrobial Factors ofInternational journal of molecular sciences · 2023
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Álvaro Rodríguez-GarcíaBiotechnology and Biosciences Research Group, Faculty of Chemical Sciences and Engineering, Autonomous University of Baja California, Tijuana 22390, Mexico.
Rosa E Mares-AlejandreBiotechnology and Biosciences Research Group, Faculty of Chemical Sciences and Engineering, Autonomous University of Baja California, Tijuana 22390, Mexico.ORCID 0000-0001-6102-6966
Patricia L A Muñoz-MuñozBiotechnology and Biosciences Research Group, Faculty of Chemical Sciences and Engineering, Autonomous University of Baja California, Tijuana 22390, Mexico.ORCID 0000-0001-8303-6305
Samuel Ruvalcaba-RuizClinical Diagnostic Laboratory, General Hospital of Tijuana, Tijuana 22010, Mexico.
Ricardo A González-SánchezDepartment of Biomedical Innovation, Center for Scientific Research and Higher Education at Ensenada, Ensenada 22860, Mexico.ORCID 0000-0003-1984-7933
Johanna Bernáldez-SarabiaDepartment of Biomedical Innovation, Center for Scientific Research and Higher Education at Ensenada, Ensenada 22860, Mexico.
Samuel G Meléndez-LópezBiotechnology and Biosciences Research Group, Faculty of Chemical Sciences and Engineering, Autonomous University of Baja California, Tijuana 22390, Mexico.ORCID 0000-0001-7392-283X
Alexei F Licea-NavarroDepartment of Biomedical Innovation, Center for Scientific Research and Higher Education at Ensenada, Ensenada 22860, Mexico.ORCID 0000-0003-4022-7405
Marco A Ramos-IbarraBiotechnology and Biosciences Research Group, Faculty of Chemical Sciences and Engineering, Autonomous University of Baja California, Tijuana 22390, Mexico.ORCID 0000-0002-8950-2079

Funding

Consejo Nacional de Ciencia y Tecnología CB-2019/01-170715Universidad Autónoma de Baja California CPI/300/2344Universidad Autónoma de Baja California CPI/300/2596Universidad Autónoma de Baja California CPI/300/735/E
6 · The paper itself

Abstract

Globally, tuberculosis (TB) remains a prevalent threat to public health. In 2019, TB affected 10 million people and caused 1.4 million deaths. The major challenge for controlling this infectious disease is the emergence and spread of drug-resistant

Indexed as

biocomputational analysisclinical isolatesmolecular analysisMycobacterium tuberculosisstreptomycin resistance

Identifiers

PMID34356728
PMCPMC8300841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.